2
Clinical Trials associated with Anti-BCMA CAR T cells(Allife Medicine)An open-label, single-center and randomized controlled trial for anti-BCMA CAR-T cells with chemotherapy agents conditioning for patients with R/R plasma cell malignancies
Start Date11 Feb 2019 |
Sponsor / Collaborator- |
Clinical Study on the Safety and Efficacy of Anti-BCMA CAR T Cells With Relapsed and Refractory Multiple Myeloma
This is a single centre、single arm、open-label,to investigate the safety and efficacy of anti-BCMA CAR T cells in patients with Relapsed and Refractory multiple myeloma.
100 Clinical Results associated with Anti-BCMA CAR T cells(Allife Medicine)
100 Translational Medicine associated with Anti-BCMA CAR T cells(Allife Medicine)
100 Patents (Medical) associated with Anti-BCMA CAR T cells(Allife Medicine)
100 Deals associated with Anti-BCMA CAR T cells(Allife Medicine)